Our FREE Wellness E-mails - focused on the mind, the body, and healthy eating - are just a click away!

GET E-MAIL!
Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons

BY IN MCofNYC On 14-07-2018

Simon Akerman, Philip R. Holland, and Peter J. Goadsby
Headache Group, Institute of Neurology and the National Hospital for Neurology and Neurosurgery, Queen Square, London,
United Kingdom
Received April 29, 2006; accepted October 2, 2006

ABSTRACT
Migraine is a common and disabling neurological disorder that involves activation or the perception of activation of the trigeminovascular system. Cannabinoid (CB) receptors are present in brain and have been suggested to be antinociceptive. Here we determined the effect of cannabinoid receptor activation on … [CONTINUE READING / FULL PDF]


SHARE THIS ON:

3 months ago / Comments Off on Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular Neurons

14

JUL

No

Comments

Medical Clinics of NYC

We are committed to increasing the accessibility to quality medical care for all of our patients through conveniently-located offices and extended hours. Many of our offices are open evenings, weekends, and holidays.

Comments are closed here.